{"title":"Exploring bio-nanomaterials as antibiotic allies to combat antimicrobial resistance.","authors":"Bindiya Barsola, Shivani Saklani, Diksha Pathania, Priyanka Kumari, Sonu Sonu, Sarvesh Rustagi, Pardeep Singh, Pankaj Raizada, Tae Seok Moon, Ajeet Kaushik, Vishal Chaudhary","doi":"10.1088/1758-5090/ad6b45","DOIUrl":null,"url":null,"abstract":"<p><p>Antimicrobial resistance (AMR) poses an emergent threat to global health due to antibiotic abuse, overuse and misuse, necessitating urgent innovative and sustainable solutions. The utilization of bio-nanomaterials as antibiotic allies is a green, economic, sustainable and renewable strategy to combat this pressing issue. These biomaterials involve green precursors (e.g. biowaste, plant extracts, essential oil, microbes, and agricultural residue) and techniques for their fabrication, which reduce their cyto/environmental toxicity and exhibit economic manufacturing, enabling a waste-to-wealth circular economy module. Their nanoscale dimensions with augmented biocompatibility characterize bio-nanomaterials and offer distinctive advantages in addressing AMR. Their ability to target pathogens, such as bacteria and viruses, at the molecular level, coupled with their diverse functionalities and bio-functionality doping from natural precursors, allows for a multifaceted approach to combat resistance. Furthermore, bio-nanomaterials can be tailored to enhance the efficacy of existing antimicrobial agents or deliver novel therapies, presenting a versatile platform for innovation. Their use in combination with traditional antibiotics can mitigate resistance mechanisms, prolong the effectiveness of existing treatments, and reduce side effects. This review aims to shed light on the potential of bio-nanomaterials in countering AMR, related mechanisms, and their applications in various domains. These roles encompass co-therapy, nanoencapsulation, and antimicrobial stewardship, each offering a distinct avenue for overcoming AMR. Besides, it addresses the challenges associated with bio-nanomaterials, emphasizing the importance of regulatory considerations. These green biomaterials are the near future of One Health Care, which will have economic, non-polluting, non-toxic, anti-resistant, biocompatible, degradable, and repurposable avenues, contributing to sustainable development goals.</p>","PeriodicalId":8964,"journal":{"name":"Biofabrication","volume":" ","pages":""},"PeriodicalIF":8.2000,"publicationDate":"2024-08-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biofabrication","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1088/1758-5090/ad6b45","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}
引用次数: 0
Abstract
Antimicrobial resistance (AMR) poses an emergent threat to global health due to antibiotic abuse, overuse and misuse, necessitating urgent innovative and sustainable solutions. The utilization of bio-nanomaterials as antibiotic allies is a green, economic, sustainable and renewable strategy to combat this pressing issue. These biomaterials involve green precursors (e.g. biowaste, plant extracts, essential oil, microbes, and agricultural residue) and techniques for their fabrication, which reduce their cyto/environmental toxicity and exhibit economic manufacturing, enabling a waste-to-wealth circular economy module. Their nanoscale dimensions with augmented biocompatibility characterize bio-nanomaterials and offer distinctive advantages in addressing AMR. Their ability to target pathogens, such as bacteria and viruses, at the molecular level, coupled with their diverse functionalities and bio-functionality doping from natural precursors, allows for a multifaceted approach to combat resistance. Furthermore, bio-nanomaterials can be tailored to enhance the efficacy of existing antimicrobial agents or deliver novel therapies, presenting a versatile platform for innovation. Their use in combination with traditional antibiotics can mitigate resistance mechanisms, prolong the effectiveness of existing treatments, and reduce side effects. This review aims to shed light on the potential of bio-nanomaterials in countering AMR, related mechanisms, and their applications in various domains. These roles encompass co-therapy, nanoencapsulation, and antimicrobial stewardship, each offering a distinct avenue for overcoming AMR. Besides, it addresses the challenges associated with bio-nanomaterials, emphasizing the importance of regulatory considerations. These green biomaterials are the near future of One Health Care, which will have economic, non-polluting, non-toxic, anti-resistant, biocompatible, degradable, and repurposable avenues, contributing to sustainable development goals.
由于抗生素的滥用、过度使用和误用,抗菌素耐药性(AMR)对全球健康构成了新的威胁,因此迫切需要创新和可持续的解决方案。利用生物纳米材料作为抗生素盟友,是应对这一紧迫问题的绿色、经济、可持续和可再生战略。这些生物材料涉及绿色前体(如生物废料、植物提取物、精油、微生物和农业残留物)及其制造技术,可降低其细胞/环境毒性,并表现出经济的制造方式,从而实现从废物到财富的循环经济模块。生物纳米材料具有纳米级尺寸和更强的生物相容性,在应对 AMR 方面具有独特的优势。生物纳米材料能够在分子水平上靶向细菌和病毒等病原体,再加上其多样化的功能性以及从天然前体中掺入的生物功能性,使得生物纳米材料能够以多层面的方式对抗抗药性。此外,生物纳米材料可以量身定制,以增强现有抗菌剂的功效或提供新型疗法,从而为创新提供了一个多功能平台。将生物纳米材料与传统抗生素结合使用,可减轻抗药性机制,延长现有疗法的疗效,并减少副作用。本综述旨在阐明生物纳米材料在对抗 AMR 方面的潜力、相关机制及其在各个领域的应用。这些作用包括共同治疗、纳米封装和抗菌管理,每种作用都为克服 AMR 提供了独特的途径。此外,该书还探讨了与生物纳米材料相关的挑战,强调了监管考虑因素的重要性。这些绿色生物材料是 "一种医疗保健 "的不远的将来,它们将具有经济、无污染、无毒、抗抗性、生物相容性、可降解和可再利用的途径,有助于实现可持续发展目标。
期刊介绍:
Biofabrication is dedicated to advancing cutting-edge research on the utilization of cells, proteins, biological materials, and biomaterials as fundamental components for the construction of biological systems and/or therapeutic products. Additionally, it proudly serves as the official journal of the International Society for Biofabrication (ISBF).